TSE:SLF

Sun Life Financial Inc (SLF.TO)

102.80
+1.38 (1.36%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
720 watching
0
Investor Insights
star iconJun 5, 2026, 12:00 am

This summary was created by AI, based on 12 opinions in the last 12 months.

Sun Life Financial Inc (SLF) is presently facing a challenging landscape, with mixed reviews from experts highlighting both the strengths and weaknesses of the company. Some analysts praise its strong management and growth potential in Asia, particularly in asset management, whereas others express concerns regarding its performance in the U.S. dental market and overall growth, particularly as compared to peers like Manulife Financial Corporation (MFC). Despite trading at a lower P/E ratio compared to Canadian banks, some experts argue that the stock's current valuation isn't compelling given the subdued growth prospects. However, SLF is recognized for its consistent dividend growth and stable earnings, and the recent share repurchases are seen as a positive move. Analysts are divided, with some asserting a long-term bullish outlook while others remain cautious pending macroeconomic or company-specific catalysts.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
MFC
TOP PICK

He considers this a healthy yield that is likely to grown. It trades at only 11x earnings. It will be a beneficiary of rising interest rates, which he expects to continue. He expects 10% earnings growth for the next 3 years. This is the largest foreign insurer in Asia (India), which offers huge growth possibilities. Its MFS American operations have turned around. Yield 3.8%. (Analysts’ price target $58.54)

SELL

The expectation is that the rate is going to invert next year. That is not good for banks and particularly bad for insurance companies. If you believe that next year is the great inversion, you don’t want to own any financials. Avoid.

COMMENT

He likes the life insurance industry and owns three companies in that space. Sun Life is the Canadian company that he likes. He prefers it to Manulife. He thinks it is better managed, with better exposure to interest rates. He likes the amount and quality of international diversification of Sun Life.

DON'T BUY

Today, everything in financials rallied, including the lifecos. Rising rates benefit them. But the US banks look better. Instead, look at the ETF, KIE-N, to give you a basket of insurance companies. Today it broke new highs. SLF isn't the best house in a very good neighbourhood.

TOP PICK

Cash flow from US and Canadian life insurance businesses they use to reinvest in growing markets in Asia. They have excess capital at the holdco level that can be used for acquisitions, pay dividend or buyback shares. (3.7% dividend, Analysts' price target: $58.57)

HOLD

He likes the insurance group as a whole, as it trades at 1.4 times book and and 10-11 times earnings. He feels this is the most expensive of the Big 3 in the group and so would favour others.

BUY

Life Insurance companies do better when interest rates rise because they reinvest their premiums, mainly in the bond market. Interest rates have not increased as much as he hoped; instead, the yield curve is flattening. He expects interest rates to rise in the future, though, and he owns Sun Life in that expectation. He thinks that over the near term, Sun Life will perform better than the Canadian banks as interest rates move up. Interest rates will rise because the economy is doing better and inflation is coming back, caused by labour shortages and tariffs.

WAIT

Numbers aren’t that bad, however has always traded at a premium compared to peers. Mutual fund side has had significant withdrawals, and so the stock sold off. Well managed, but technically it has broken down. If goes down to $48, a definite buy. But not right now.

BUY ON WEAKNESS

He likes it. It is a good insurance name, trading to a premium to other insurance names out there. They are looking for acquisitions where they can add to their portfolios. Nice dividend. Rising interest rates should benefit it. They have growth in Asian.

PAST TOP PICK

(A Top Pick September 7/17 Up 18%) This will be a big beneficiary if the yield curve steepens. They have grown their business in Asia, the US and India. He looks for 10% earnings growth annually and further expansion of the dividend.

WAIT

Buy or sell? Caught in a trading range on the chart. If it gets up to $54-55 range, sell, and then buy it back closer to $50. Not a bad yield, relatively safe. But until it shows signs of breaking out, better yields elsewhere.

BUY

It is the safe, steady lifeco. They are in a dividend growing mode. It is a great company to own. A company they own in the US has had redemption issues, but it is a great company to retire on.

COMMENT

Manulife (MFC-T) versus Sunlife (SLF-T). He owned Manulife going into the financial crisis, but became concerned about management and sold out of their holdings. When Sunlife began to fall in sympathy they bought them – focusing on the preferred shares in particular. Manulife still has some questionable assets in the US and may not know how to offload them.

COMMENT

He likes lifecos for the long haul because society is aging for longer, so the lifecos defer their payouts longer. However, profitability in this business lies in the long-term disability sector, but no company now has a competitive advantage here. Look out for the one that does by reading their reports for what they say about disability insurance management.

COMMENT

Technical analysis: The buyers are still buying despite the stock hitting a top, while sellers are waiting for higher prices to sell. The buyers have more conviction than the sellers.

Showing 151 to 165 of 1,049 entries